TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients
TNFR2+ TIL 与三阴性乳腺癌患者的生存率提高显著相关
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-020-02549-0
Maya Dadiani #, Daniela Necula #, Smadar Kahana-Edwin #, Nino Oren #, Tamir Baram #, Irina Marin, Dana Morzaev-Sulzbach, Anya Pavlovski, Nora Balint-Lahat, Liat Anafi, Stefan Wiemann, Cindy Korner, Einav Nili Gal-Yam, Camila Avivi, Bella Kaufman, Iris Barshack, Adit Ben-Baruch
